05.17.18 Syndax Announces Updated Results from Phase 2 ENCORE 601 Trial of Entinostat in Combination with KEYTRUDA® (pembrolizumab)
05.08.18 Syndax Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Clinical and Business Update
05.01.18 Syndax to Announce First Quarter 2018 Financial Results and Host Conference Call and Webcast on May 8, 2018
04.25.18 Syndax Pharmaceuticals Announces Presentations at the 2018 American Society of Clinical Oncology Annual Meeting
